Aura Biosciences Inc (AURA) — Financial Flexibility Index
Aura Biosciences Inc (AURA) has a Financial Flexibility Index of -0.98x as of March 2026. Free cash flow of $-29.79 Million (operating CF $-29.89 Million minus capex $102.00K) represents -1% of total liabilities ($30.43 Million). Check AURA tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aura Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Aura Biosciences Inc across 7 annual periods. For the full cash flow conversion analysis, see AURA operating cash flow.
Annual Financial Flexibility Index for Aura Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Aura Biosciences Inc. Explore AURA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.59x | $-84.30 Million | $-84.74 Million | $32.52 Million | ▼ -0.8% |
| 2024 | -2.57x | $-78.55 Million | $-79.81 Million | $30.53 Million | ▼ -19.1% |
| 2023 | -2.16x | $-63.14 Million | $-63.85 Million | $29.23 Million | ▼ -14.5% |
| 2022 | -1.89x | $-53.51 Million | $-54.60 Million | $28.35 Million | ▲ +51.9% |
| 2021 | -3.93x | $-30.29 Million | $-32.41 Million | $7.71 Million | ▲ +54.3% |
| 2020 | -8.59x | $-23.55 Million | $-24.32 Million | $2.74 Million | ▼ -193.1% |
| 2019 | -2.93x | $-18.45 Million | $-20.67 Million | $6.29 Million | — |